Randomized, Open-Label Phase 3 Trial of Nivolumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Randomized, Open-Label Phase 3 Trial of Nivolumab versus Platinum-Doublet Chemotherapy in Early Stage NSCLC

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.